Public-private partnerships: A factor of competitive advantage enhancement

Public-Private Partnerships

Public private partnerships: a marriage of necessity.

Harnessing the unprecedented flexibility that iPSC technology and gene editing offer academic and industry-based researchers requires developing an interactive model of collaboration. Such a model will have to leverage the basic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and high throughput technology to be successful.

Finance and Public-Private Partnerships

A PPP bundles investment and service provision of infrastructure into a single long-term contract. A group of private investors finances and manages the construction of the project, then maintains and operates the facilities for a long period of usually 20 to 30 years, and at the end of the contract transfers the assets to the government. During the operation of the project, the private partner...

Public-private partnerships: an overview.

The development and marketing of medicines needed specifically to combat diseases of the developing world are commercially unattractive because the populations concerned are among the poorest on earth. Partnerships which bring together pharmaceutical companies, academics, not-for-profit organizations, philanthropists, governmental and inter-governmental agencies are an increasingly popular solu...

2.1.3. Global Public-Private Partnerships

We amply dealt with the history and evolution of partnerships, which culminated in the setting up of Global Public Private Partnerships (GPPPs) focusing on health programmes, in the first report of the Osservatorio Italiano sulla Salute Globale1 (Italan Global Health Watch) in 2004. Some authors have argued that the GPPP phenomenon is linked to structural changes, and destined to consolidate it...